Table 36: Drugs in Development, 2015 138 Table 37: China Sales Forecast($ m) for DES Therapies, 2014-2024 140 Table 38: Key Events Impacting Sales for DES in China, 2014-2024 141 Table 39: DES Market- Drivers and Barriers in China, 2014-2024 141 Table 40: Key Launch Dates 181 Table 41: Surveyed High-prescribing Physicians, by Country 188
List of Figures Figure 1: Dry Eye Syndrome- Disease Etiology 12 Figure 2: The Tear Film in normal and dry eye 15 Figure 3: Varied Symptoms of Dry Eye Syndrome 20
Browse Complete Summary Click Here @ http:// www. radiantinsights. com / research / dry-eyesyndrome-china-drug-forecast-and-market-analysis-to-2024
Figure 4: Dry Eye Syndrome Therapeutics- Phase II and II / III Clinical Trials in the 9MM, 2015 100 Figure 5: DES Phase II / Phase III Pipeline, 2015 103 Figure 6: Competitive Assessment of Late-Stage Pipeline Agents in DES, 2014-2024 104 Figure 7: Clinical and Commercial Positioning of lifitegrast 111 Figure 8: Clinical and Commercial Positioning of tavilermide 117 Figure 9: Clinical and Commercial Positioning of Visomitin 123 Figure 10: Clinical and Commercial Positioning of RGN-259 129 Figure 11: Drug Sales for DES Therapies in China, 2014 and 2024 140 About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships / tie-ups and customized research solutions.